viewTekcapital PLC

Tekcapital flags distribution deal for portfolio company Salarius

Salarius is the developer and manufacturer of a proprietary low sodium salt called MicroSalt

Tekcapital PLC -

Tekcapital PLC (LON:TEK) shares rose on Monday as the UK intellectual property investment group said its portfolio company Salarius has signed a distribution agreement for its Saltme! snack brand.

The agreement covers North America and is with one of North America's largest natural food wholesalers.

Tekcapital said the agreement represents an important milestone for Salarius's new potato crisp snack line, enabling “unprecedented reach” of SaltMe! products into consumer outlets of every size in North America.

Purchase orders and shipping of the product are expected to commence in the second quarter of this year to multiple distribution centres for all four flavour crisps being launched by the company.

"We are very glad to see that Salarius has signed an agreement with one of the largest natural food distributors for its SaltMe! potato crisps. This is a terrific milestone for the company and underscores our core belief that when you combine vibrant intellectual property with star-power management, exciting things can happen," said TekCapital's executive chairman, Clifford Gross.

Tekcapital has a 91.7% stake in Salarius.

In early afternoon trading, shares in TekCapital were 12.5% higher at 4.50p.

 -- Adds share price -- 


Quick facts: Tekcapital PLC

Price: 14.4425 GBX

Market: LSE
Market Cap: £12.68 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Tekcapital PLC named herein, including the promotion by the Company of Tekcapital PLC in any Content on the Site, the Company receives from...



Full interview: LexaGene hits milestone by having pre-commercial device in...

LexaGene (CVE: LXG- OTCQB: LXXGF) CEO Dr Jack Regan joined Steve Darling from Proactive Vancouver with news the company now has one of their devices that tests for COVID-19 and other respiratory pathogens being used at the Dartmouth-Hitchcock Medical Center in Hanover, New Hampshire. Regan...

16 hours, 21 minutes ago

2 min read